ノースカロライナにおける骨髄線維症の臨床試験
ノースカロライナ内の拠点で、骨髄線維症に関する17件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Duke Cancer Institute, Durham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04176198A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Duke Blood Cancer Center, Durham
- Novant Health, Winston-Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07623161A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Cabarrus/LCI-Concord, Concord
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06661915Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Atrium Health Wake Forest Baptist, Winston-Salem
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT05320198A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
- Levine Cancer Institute, Charlotte
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06343805A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- University of North Carolina At Chapel Hill, Chapel Hill
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/06更新 · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- University of North Carolina At Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT07441694Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- 他4件
被験者募集中観察研究
65歳以上 · 全性別 · 2026/06/29更新 · NCT01137825Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
- Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT05835466Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- University of North Carolina, Chapel Hill
被験者募集中第1相
13歳以上 · 全性別 · 2026/05/05更新 · NCT04771572A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Wake Forest Baptist Medical Center, Winston-Salem
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/17更新 · NCT06034002A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/02更新 · NCT06351631A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of North Carolina, Chapel Hill
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Duke University, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/12更新 · NCT05980806SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
被験者募集中観察研究
18歳〜120歳 · 全性別 · 2025/10/27更新 · NCT01137643Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Medical University of South Carolina (MUSC), Charleston
- Atrium Health Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2025/09/25更新 · NCT06479135ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。